Sponsor:
Ohio State University Comprehensive Cancer Center
Code:
NCT06741072
Conditions
Chronic Kidney Disease, Stage 4
Chronic Kidney Disease, Stage 5
EBV-Related Lymphoproliferative Disorder
EBV-Related Malignant Neoplasm
Post-Transplant Lymphoproliferative Disorder
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Biospecimen Collection
Dulbecco''s Phosphate-Buffered Saline
Peptide Vaccine
QS21
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-18. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2025-10-15.